2,757 Shares in Centene Co. (NYSE:CNC) Purchased by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Centene Co. (NYSE:CNC) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,757 shares of the company’s stock, valued at approximately $167,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Atria Wealth Solutions Inc. increased its position in shares of Centene by 23.4% during the 4th quarter. Atria Wealth Solutions Inc. now owns 9,710 shares of the company’s stock worth $588,000 after purchasing an additional 1,842 shares during the last quarter. D.A. Davidson & CO. acquired a new stake in shares of Centene during the 4th quarter worth about $3,378,000. CIBC Asset Management Inc increased its position in shares of Centene by 1.2% during the 4th quarter. CIBC Asset Management Inc now owns 77,798 shares of the company’s stock worth $4,713,000 after purchasing an additional 905 shares during the last quarter. Capital Performance Advisors LLP increased its position in shares of Centene by 37.4% during the 4th quarter. Capital Performance Advisors LLP now owns 3,551 shares of the company’s stock worth $215,000 after purchasing an additional 967 shares during the last quarter. Finally, AustralianSuper Pty Ltd boosted its holdings in Centene by 3.8% during the 4th quarter. AustralianSuper Pty Ltd now owns 1,414,439 shares of the company’s stock valued at $85,687,000 after acquiring an additional 52,082 shares during the period. 93.63% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CNC. Sanford C. Bernstein lowered their target price on Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. Argus cut Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Cantor Fitzgerald restated an “overweight” rating and set a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. Truist Financial lowered their target price on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Finally, Robert W. Baird raised their target price on Centene from $66.00 to $71.00 in a report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.92.

Insider Transactions at Centene

In other news, Director Theodore R. Samuels II purchased 5,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were bought at an average price of $58.86 per share, with a total value of $294,300.00. Following the completion of the transaction, the director now directly owns 23,000 shares in the company, valued at approximately $1,353,780. This represents a 27.78 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director H James Dallas purchased 1,693 shares of the business’s stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of $59.01 per share, for a total transaction of $99,903.93. Following the transaction, the director now owns 1,693 shares of the company’s stock, valued at $99,903.93. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 23,693 shares of company stock valued at $1,409,954. Corporate insiders own 0.33% of the company’s stock.

Centene Price Performance

Shares of NYSE CNC opened at $58.50 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $81.42. The firm has a market capitalization of $29.54 billion, a PE ratio of 9.38, a price-to-earnings-growth ratio of 0.75 and a beta of 0.45. The stock’s 50-day simple moving average is $61.05 and its 200-day simple moving average is $66.03.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion for the quarter, compared to analyst estimates of $38.78 billion. During the same quarter last year, the company earned $0.45 EPS. The business’s quarterly revenue was up 3.4% on a year-over-year basis. As a group, equities research analysts forecast that Centene Co. will post 7.01 EPS for the current fiscal year.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.